ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Other Receivables
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Other Receivables of $772.39 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2019-12-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2019-12-16
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for the quarter ending 2014-03-31 was $0.00.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for the quarter ending 2013-12-31 was $0.00.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for the quarter ending 2013-09-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for the quarter ending 2013-06-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for fiscal 2019 was $772.39K, a 234.23% increase from fiscal 2018.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for fiscal 2018 was $231.10K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for fiscal 2013 was $0.00.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in other receivables for fiscal 2012 was -$809.00.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 89 month | Increase (Decrease) in Other Receivables 92 month | Increase (Decrease) in Other Receivables 95 month | Increase (Decrease) in Other Receivables 98 month | Increase (Decrease) in Other Receivables 101 month | Increase (Decrease) in Other Receivables 104 month | Increase (Decrease) in Other Receivables 107 month | Increase (Decrease) in Other Receivables 110 month | Increase (Decrease) in Other Receivables 113 month | Increase (Decrease) in Other Receivables 116 month | Increase (Decrease) in Other Receivables 119 month | Increase (Decrease) in Other Receivables 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | $772.39K 10-K · filed 2019-12-16 | |||||||||||||||
| 2018-09-30 | $231.10K 10-K · filed 2019-12-16 | |||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 derived: sum of 3 quarters · filed 2014-05-30 | $0.00 derived: sum of 4 quarters · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | |||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $0.00 derived: sum of 3 quarters · filed 2014-02-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-30 | $0.00 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $0.00 derived: sum of 2 quarters · filed 2013-12-30 | $0.00 derived: sum of 3 quarters · filed 2014-05-30 | $0.00 10-K · filed 2013-12-30 | $0.00 10-K · filed 2013-12-30 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-30 | $0.00 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 derived: sum of 3 quarters · filed 2014-05-30 | -$953.00 derived: sum of 4 quarters · filed 2014-05-30 | $0.00 10-Q · filed 2013-05-17 | |||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | -$953.00 derived: sum of 3 quarters · filed 2014-02-14 | -$3.05K derived: sum of 4 quarters · filed 2014-02-14 | $0.00 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | -$953.00 derived: sum of 2 quarters · filed 2013-12-30 | -$3.05K derived: sum of 3 quarters · filed 2013-12-30 | -$809.00 10-K · filed 2013-12-30 | $0.00 10-K · filed 2012-12-31 | |||||||||||
| 2012-06-30 | -$953.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | -$3.05K derived: sum of 2 quarters · filed 2013-08-14 | -$809.00 10-Q · filed 2013-08-14 | -$21.36K derived: sum of 4 quarters · filed 2013-08-14 | $0.00 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | -$2.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17 | $144.00 10-Q · filed 2013-05-17 | -$20.41K derived: sum of 3 quarters · filed 2013-05-17 | -$7.71K derived: sum of 4 quarters · filed 2013-05-17 | $953.00 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $2.24K 10-Q · filed 2013-02-14 | -$18.31K derived: sum of 2 quarters · filed 2013-02-14 | -$5.61K derived: sum of 3 quarters · filed 2013-02-14 | $3.05K derived: sum of 4 quarters · filed 2013-02-14 | $3.05K 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | -$20.55K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | -$7.85K derived: sum of 2 quarters · filed 2012-12-31 | $809.00 derived: sum of 3 quarters · filed 2012-12-31 | -$37.01K 10-K · filed 2012-12-31 | $809.00 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $12.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | $21.36K derived: sum of 2 quarters · filed 2012-08-17 | -$16.46K 10-Q · filed 2012-08-17 | $21.36K 10-Q · filed 2011-08-12 | ||||||||||||
| 2011-03-31 | $8.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | -$29.16K 10-Q · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | -$37.82K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | $37.82K 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |